Biological sex differences in pharmacokinetics and adverse drug reactions
Open accessThe DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
Abstract
Although physiological and hormonal differences between males and females can significantly alter drug absorption, distribution, metabolism, and excretion (ADME), most current pharmacotherapeutic guidelines remain sex neutral. The chapter aims to elucidate biological sex-specific factors across all pharmacokinetic (PK) phases, subsequent therapeutic efficacy, and adverse drug reactions (ADRs), and to highlight implications for individualized therapy including within-woman variation across the menstrual cycle and other hormonal states. This work is based on an extensive review of current literature and clinical data examining sex-specific variations across all phases of pharmacokinetics. Significant biological sex-related differences were found among all PK phases. Females tend to have slower gastric emptying, higher body fat composition, and lower glomerular filtration rates. CYP3A4 is typically more active in females, while CYP1A2, CYP2D6, and CYP2E1 show greater activity in males. In females, endogenous or exogenous hormonal fluctuation can slightly affect gastric motility, protein binding, and selected CYP activities altering clearance for susceptible drugs. In addition, pregnancy increases plasma volume and glomerular filtration with predictable effects on renally cleared drugs and selected hepatic pathways. These differences influence drug half-life, systemic exposure, and the risk of ADRs. Biological sex is a significant determinant of drug pharmacokinetics. Integrating biological sex-specific data into clinical guidelines is essential to optimize drug efficacy and minimize ADRs. Future research and regulatory action should promote biological sex aware pharmacological practices, encouraging routine inclusion of biological sex analyses in clinical trials. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex differences in pharmacokinetics and plasticity trajectories remain largely unmapped, despite evidence that network biomarkers and treatment prediction are sensitive to demographic and biological heterogeneity [93,232,233,234].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [233]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–252 of 252
Matthaei, J., Tzvetkov, M., Strube, J., Sehrt, D., Sachse‐Seeboth, C., Hjelmborg, J., Möller, S., Halekoh, U., Hofmann, U., Schwab, M., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.444 · Cited by 38
Chaira, T., Subramani, C., & Barman, T. K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041212 · Cited by 38
Neuere Antipsychotika: Unterschiede im Nebenwirkungsprofil bei Frauen und Männern
Aichhorn, W., Whitworth, A. B., Weiss, E. M., Hinterhuber, H., & Marksteiner, J. (2006) · Der Nervenarzt · doi:10.1007/s00115-006-2112-0 · Cited by 37
Effect of patient-specific factors on weekly warfarin dose.
Whitley, H. P., Fermo, J. D., Chumney, E. C. G., & Brzezinski, W. A. (2007) · PubMed Central · Cited by 36
Vree, T. B., Dammers, E., Ulč, I., Horkovics-Kovats, S., Ryska, M., & Merkx, I. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.121 · Cited by 35
Relative potency of vecuronium in male and female patients in Britain and Australia
Semple, P., HOPE, D. A., Clyburn, P. A., & Rodbert, A. (1994) · British Journal of Anaesthesia · doi:10.1093/bja/72.2.190 · Cited by 35
Factors affecting drug biotransformation
Renton, K. W. (1986) · Clinical Biochemistry · doi:10.1016/s0009-9120(86)80051-0 · Cited by 33
Liu, Y., Li, J., & Zhu, H. (2024) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2024.2348491 · Cited by 33
McBurney, M. I. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529109037025 · Cited by 32
Johnson, J. A., Akers, W. S., Herring, V. L., Wolfe, M. S., & Sullivan, J. M. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.7.622.35180 · Cited by 31
Alterations in prednisolone disposition as a result of oral contraceptive use and dose.
Meffin, P. J., Wing, L., Sallustio, B., & Brooks, P. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02400.x · Cited by 31
Setting occupational health standards: toxicokinetic differences among and between men and women.
Silvaggio, T., & Mattison, D. R. (1994) · PubMed · Cited by 31
Gastric emptying in pregnancy and its clinical implications: a narrative review
Lawson, J., Howle, R., Popivanov, P., Sidhu, J., Gordon, C., Leong, M., Onwochei, D. N., & Desai, N. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.09.005 · Cited by 30
Zimmermann, T., Laufen, H., Yeates, R. A., Scharpf, F., Riedel, K., & Schumacher, T. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922011782 · Cited by 29
Succari, M., Foglietti, M. J., & Percheron, F. (1990) · Clinica Chimica Acta · doi:10.1016/0009-8981(90)90108-5 · Cited by 29
Vasicka, A., & BRIGHT, R. H. (1957) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-195702000-00001 · Cited by 29
Effect of Gender on the Pharmacokinetics of Ofloxacin
Sowinski, K. M., Abel, S. R., Clark, W. R., & Mueller, B. A. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.6.442.31044 · Cited by 29
Paracetamol pharmacokinetics and metabolism in young women
Allegaert, K., Peeters, M. Y. M., Beleyn, B., Smits, A., Kulo, A., Calsteren, K. V., Deprest, J. A., Hoon, J. N. J. M. D., & Knibbe, C. A. J. (2015) · BMC Anesthesiology · doi:10.1186/s12871-015-0144-3 · Cited by 29
Eugene, A. (2016) · Medical Sciences · doi:10.3390/medsci4040018 · Cited by 29
Quinney, S. K., Mohamed, A., Hébert, M. F., Haas, D. M., Clark, S., Umans, J., Caritis, S. N., & Li, L. (2012) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.5 · Cited by 29
Influence of oral contraceptives on drug therapy
Teichmann, A. T. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90563-m · Cited by 28
Wong, O., Marshall, K., Sicova, M., Guest, N. S., García‐Bailo, B., & El‐Sohemy, A. (2021) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2020-0395 · Cited by 28
Hong, J.-Y., Park, J. W., & Oh, J. I. (2005) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2004.10.010 · Cited by 27
Dispelling the Myths: Calling for Sex-Specific Reporting of Trial Results
Hayes, S. N., & Redberg, R. F. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.5.523 · Cited by 26
Shang, J., Huang, L., Huang, J., Ren, X., Liu, Y., & Feng, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.871372 · Cited by 25
Walle, T., Fagan, T. C., Walle, U. K., & Topmiller, M. J. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.03097.x · Cited by 24
Nimmen, N. F. J. V., Poels, K. L. C., Menten, J., Godderis, L., & Veulemans, H. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347872 · Cited by 24
Serum Group I Pepsinogens During Pregnancy
Waldum, H. L., Straume, B., & Lundgren, R. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181433 · Cited by 24
Alpha‐1‐Acid Glycoprotein Concentration and the Protein Binding of Disopyramide in Healthy Subjects
Kishino, S., Nomura, A., Di, Z. S., Sugawara, M., Iseki, K., Kakinoki, S., Kitabatake, A., & Miyazaki, K. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04096.x · Cited by 23
Bramness, J. G., Skurtveit, S. O., Gulliksen, M., Breilid, H., Steen, V. M., & Mørland, J. G. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0970-1 · Cited by 23
Increased theophylline metabolism in the menstrual phase of healthy women☆☆☆★
Nagata, K., Ishitobi, K., Yamamoto, Y., Ikeda, T., Hori, S., Matsumoto, Y., & Sasaki, T. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70192-1 · Cited by 22
Edelbroek, P. M., Zitman, F. G., der Klein, E. A. M. K.-V., Putten^, P. M. V., & de Wolff, F. A. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90161-6 · Cited by 21
Population Pharmacokinetics of Continuous Infusion Ceftazidime
Frame, B. C., Facca, B., Nicolau, D. P., & Triesenberg, S. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937040-00005 · Cited by 21
Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.
Mönig, H., BAESE, C., Heidemann, H., Ohnhaus, E., & Schulte, H. M. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03750.x · Cited by 20
Pietrauszka, K., & Bergler-Czop, B. S. (2020) · Advances in Dermatology and Allergology · doi:10.5114/ada.2020.99947 · Cited by 20
Her, L., Wang, X., Shi, J., Choi, H. J., Jung, S. M., Smith, L. S., Wu, A. H., Bleske, B. E., & Zhu, H. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14888 · Cited by 19
Gender Differences in Aminoglycoside Induced Nephrotoxicity: A Prospective, Hospital - Based Study
Sweileh, W. M. (2009) · Current Clinical Pharmacology · doi:10.2174/157488409789375339 · Cited by 18
Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia
Jimenez‐Cauhe, J., Vañó-Galván, S., Mehta, N. R., Hermosa‐Gelbard, Á., Ortega-Quijano, D., Buendía‐Castaño, D., Fernández‐Nieto, D., Porriño‐Bustamante, M. L., Saceda‐Corralo, D., Pindado‐Ortega, C., et al. (2024) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.16473 · Cited by 17
Winkler, M., Ringe, B., Oldhafer, K. J., Kattner, A., F�rber, L., Maib�cher, A., Wonigeit, K., & Pichlmayr, R. (1995) · Transplant International · doi:10.1007/bf00346888 · Cited by 16
Li, C. S. W., Sweeney, K., & Cronenberger, C. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03946-8 · Cited by 14
Winkler, M., Ringe, B., Oldhafer, K. J., et al. (1995) · Transplant International · doi:10.1111/j.1432-2277.1995.tb01529.x · Cited by 14
Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats
Liu, H., Magdalou, J., Nicolas, A., Lafaurie, C., & Siest, G. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90470-q · Cited by 12
Fleishaker, J. C., & Peters, G. R. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04254.x · Cited by 11
Xiang, C., Sun, Y., Luo, Y., Xie, C., Huang, W., Jones, K. L., Horowitz, M., Sun, Z., Rayner, C. K., Ma, J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15635 · Cited by 11
Reigner, B. G., & Welker, H. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.575 · Cited by 10
Lai, C. W., Jadhav, S., Njei, B. M., Ye, A., Wactawski‐Wende, J., Mumford, S. L., Schisterman, E. F., & Rotman, Y. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.047 · Cited by 10
Sex differences in pharmacokinetics of oral propranolol in healthy Chinese volunteers.
XIE, H., & Chen, X. (1995) · PubMed · Cited by 9
[Gender differences in pharmacokinetics of anesthetics].
Ueno, K. (2009) · PubMed · Cited by 9
Herman, R. J., Loewen, G., Antosh, D. M., Taillon, M., Hussein, S., & Verbeeck, R. K. (1994) · PubMed · Cited by 9
Hreiche, R., Morissette, P., Zakrzewski-Jakubiak, H., & Turgeon, J. (2009) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248408331018 · Cited by 9
Does the time of the month affect the function of the gut?
Sweeting, I. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90208-g · Cited by 8
Yang, W.-H., Xu, H., Song, Y., Wang, X., Ren, X., Zhao, D., Cai, Y., Zhang, S., Huang, J., Zhang, L., et al. (2013) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201973 · Cited by 3
Research works printed but not linked: 2
- FDA Drug Safety Communication (2013) FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR [press release]. FDA
- Onetto AJ, Sharif S (2025) Drug distribution. StatPearls. Treasure Island (FL) 33620813
Cited by
Araújo, M. R., Mendes‐Frias, A., & Silvestre, R. (2026) · Biology of Sex Differences · doi:10.1186/s13293-026-00857-1 · Cited by 12
Wang, F., Li, Y., Feng, X., Shu, Y., Zhang, C., Li, L., & Guo, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149406 · Cited by 4
Seifert, J., Grohmann, R., Toto, S., Reinhard, M. A., Bleich, S., Erfurth, A., Schüle, C., Stübner, S., & Glocker, C. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04900-7 · Cited by 5
Neamah, A. S., & Lafta, F. M. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05046-w · Cited by 2
Medication adherence in adolescents: physiological, psychosocial, and clinical perspectives
Kırmızı, N. İ., Akıcı, N., & Akıcı, A. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05122-1 · Cited by 4
Metadata
- Authors
- Aljohmani, A., & Yildiz, D.
- Affiliations
- Saarland University (DE)
- Corresponding author
- Yildiz, Daniela
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 2025-10-21
- Volume
- 399
- Issue
- 3
- Pages
- 3285-3301
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- PMC
- PMC12935741
- OpenAlex
- W4415378844
- Cited by
- 35
- References
- 248
- Citations by year
- 2026: 33 · 2025: 2
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Universität des Saarlandes
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Sex and Gender in Healthcare
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- sex differences, pharmacokinetics, adverse drug reactions, drug absorption, drug distribution, drug metabolism, drug excretion, CYP enzymes, hormonal fluctuations, menstrual cycle, pregnancy, glomerular filtration rate, gastric emptying, body fat content, personalized treatment
- MeSH terms
- Animals, Cytochrome P-450 Enzyme System, Pharmaceutical Preparations, Female, Humans, Male, Pharmacokinetics, Sex Characteristics, Sex Factors, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.